Listen Now
Topics Covered
- Overview of Diffuse Large B-Cell Lymphoma (DLBCL), Including Staging and Grading, In the Context of COVID, Seasonal Flu and RSV
- Current Standard of Care, New & Emerging Treatment Approaches
- Treatment Options for Relapsed Refractory DLBCL, Including Bispecific Antibodies
- Understanding How Bispecific Antibodies Work in the Treatment of Relapsed Refractory DLBCL
- The Role of Clinical Trials: How Research Contributes to Treatment Options
- Tips to Prevent & Manage Treatment Side Effects, Symptoms, Discomfort & Pain
- Talking with Your Health Care Team about Quality-of-Life Concerns
- Guidelines to Prepare for Telehealth/Telemedicine Appointments, Including Technology, Prepared List of Questions & Discussion of OpenNotes
- Questions for Our Panel of Experts
Our Panel of Experts
Catherine S M Diefenbach, MD
Associate Professor of Medicine, Translational Director of Hematology, Director Clinical Lymphoma, Perlmutter Cancer Center, An NCI-designated Comprehensive Cancer Center, NYU Langone Health
Belita Cowan, MA
President, Lymphoma Foundation of America
Carolyn Messner, DSW, BCD, FAPOS, FAOSW
Senior Director of Education and Training, CancerCare
Brochure
You can download the brochure for this workshop
Workshop Date
This workshop was originally recorded on June 20, 2024.